The Effect of Individualized Education Using the Teach-Back Method Treatment on Treatment Adherence and the Coping Skills
NCT ID: NCT05978479
Last Updated: 2023-08-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
64 participants
INTERVENTIONAL
2023-09-04
2023-12-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Education Hemodialysis Patients According to Roy Adaptation Model
NCT05187234
The Effect of Roy Adaptation-Based Nursing Intervention
NCT05568342
Teach Back Method on Depression Levels in Hemodialysis Patients
NCT07069634
The Effect of the Mobile Application Developed for Hemodialysis Patients on Symptoms and Disease Compliance
NCT05322291
Evaluation of the Effect of the Training Program Based on the Precede-Proceed Model on Guality Life Style
NCT05955703
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Teach-Back Method
The intervention group will be trained using the Teach Back Method in 3 sessions on every other day that will last 45-60 minutes. Training topics are hemodialysis treatment, end stage renal failure, fluid and diet restrictions and their importance, medication adherence and its importance and lifestyle rules. At the same time, patients will take education booklets.
Teach-Back Method
No intervention will be given to the patients in the control group.
Control group
No intervention will be given to the patients in the control group.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Teach-Back Method
No intervention will be given to the patients in the control group.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Individuals between the ages of 18 and 65 years,
* Having no speech, vision or hearing problems,
* Be able to speak, read and write in Turkish,
* Patients who have voluntarily to participate and informed consent form in the study.
Exclusion Criteria
* The general situation is not suitable for questioning,
* Those diagnosed with a cognitive disease such as dementia.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Saglik Bilimleri Universitesi
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ELIF ACAR
PhD student internal medicine nursing
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elif Acar, Msc.
Role: PRINCIPAL_INVESTIGATOR
University of Health science
Semiha Akın, Prof.
Role: PRINCIPAL_INVESTIGATOR
University of Health science
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SaglikBilimleriUEACAR0001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.